Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Allos Therapeutics acquires license to chemotherapeutic agent RH1

Dec. 21, 2004

Exelixis plans phase I study of XL-880 for 2005

Dec. 21, 2004

No overall survival benefit with Iressa in ISEL study

Dec. 21, 2004

Updates on Xyotax pivotal studies

Dec. 21, 2004

FDA approval for Kepivance

Dec. 20, 2004

Eligard six-month depot receives FDA approval

Dec. 20, 2004

New data on the activity of tipifarnib in acute myeloid leukemia

Dec. 20, 2004

Oblimersen not active in patients with multiple myeloma, but benefits patients with CLL

Dec. 20, 2004

DTS-201 set to enter clinical trials in Europe

Dec. 20, 2004

Cell Therapeutics enters licensing agreements for bisplatinum compounds

Dec. 20, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...